SOURCE: MIT Enterprise Forum
CAMBRIDGE, MA--(Marketwire - Nov 30, 2011) - On December 14, 2011 the MIT Enterprise Forum of Cambridge will present an Innovation Series event: "Defeating Alzheimer's." The disease devastates the lives of 25 to 40 million people worldwide -- a number projected to quadruple in the coming decades. There are no FDA-approved medicines currently that can significantly modify the course of the disease or any effective means for early detection and diagnosis, although significant research continues to find a cure.
Neurodegeneration is among the most costly and risky areas of drug development and yet presents high levels of reward. Alzheimer's is an area of tremendous scientific promise and presents an exciting business opportunity.
Keynoting the event will be:
An esteemed panel will join Dan and Ken to address these issues and opportunities including:
The event organizer is Dr. Ben Zeskind, Co-Founder and CEO, Immuneering Corporation.
When:
Wednesday, December 14, 2011
5:30pm to 6:10pm Registration
6:10-8:00pm: Program
8:00-9:00pm: Networking reception in the R&D Pub
Where: MIT Stata Center (Building 32), Kirsch Auditorium, 32 Vassar St., Cambridge, MA
Registration and information:
http://www.mitforumcambridge.org/events/innovation-series-event-solving-alzheimer%E2%80%99s/#register
Pricing: Forum members: $25, Non-members: $50. Students from all universities are free with college ID. Pre-registration is encouraged.
About The MIT Enterprise Forum of Cambridge (http://www.mitforumcambridge.org/)
The MIT Enterprise Forum of Cambridge is one of the 27 worldwide chapters of the MIT Enterprise Forum, Inc. The MIT Enterprise Forum of Cambridge builds connections to technology entrepreneurs and to the communities in which they reside. The Forum produces over 70 seminars, panel discussions, case studies and networking events yearly.